Scientific Committee

Home Scientific Committee
Thomas Caulfield, Ph.D
Founder & CEO
Digital Ether Computing, Miami, FL

Bio: Thomas R. Caulfield, PhD is the Founder & CEO of Digital Ether Computing, a frontier biotech–AI company developing Liquid Adaptive AI, the Dynamicasome, and next-generation generative models for drug discovery and protein variant interpretation. A scientist, inventor, and engineer, Dr. Caulfield has authored multiple high-impact papers and patented dozens of novel therapeutics. His work integrates advanced mathematics, quantum-inspired AI, and functional genomics to accelerate breakthrough therapeutics across complex diseases

Xiaolei Zhu, M.D., Ph.D
Assistant Professor
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine, Baltimore, MD

Bio: Xiaolei Zhu, M.D., Ph.D., is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine and Co-Director of the JH Center for the Advancement of HIV Neurotherapeutics. His research focuses on how microglial/macrophage and lymphocyte signaling contribute to neuropsychiatric and neurocognitive disorders, including chronic stress–related depression and HIV-associated brain dysfunction. Dr. Zhu’s laboratory integrates mouse models, single-cell and spatial transcriptomics, and translational therapeutic development, with a particular emphasis on microglia-directed glutaminase inhibition and gut–brain immune mechanisms. He has published in journals such as Nature Immunology, Science Translational Medicine, and Neurotherapeutics, and serves on editorial boards and scientific committees in the areas of neuroimmunology, neuroHIV, and experimental neurotherapeutics.